DUPAN-II normalisation as a biological indicator during preoperative chemoradiation therapy for resectable and borderline resectable pancreatic cancer
2023 · BMC Cancer · 6 citations
https://doi.org/10.1186/s12885-023-10512-2
T
Takashi Kanemura
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
52
Papers
235
Citations
8
h-index
6
i10-index
Takashi Kanemura is an academic researcher from Osaka International Cancer Institute. The author has contributed to research in topics: Gastric Cancer Management and Outcomes & Esophageal Cancer Research and Treatment & Silicon Carbide Semiconductor Technologies. The author has an h-index of 8, co-authored 45 publications.
Papers by this author
worksSurvival Impact of Inflammation-based Prognostic Scores in Metastatic or Unresectable Esophageal Cancer Treated With Pembrolizumab Plus Chemotherapy
2024 · Journal of Immunotherapy · 5 citations
https://doi.org/10.1097/cji.0000000000000529
Learning curve analysis for prophylactic bilateral robot-assisted lateral lymph node dissection for lower rectal cancer: a retrospective study
2025 · Techniques in Coloproctology · 3 citations
https://doi.org/10.1007/s10151-025-03119-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat